MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.leukres.2018.10.019

Медицинская библиотека · Leukemia research · 2018

Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.

Kang Ki-Hoon, Kim Soo-Hyun, Choi Soo-Young, Yoo Hae-Lyun, Lee Mi-Young, Song Hye-Young, Kee Kyung-Mi, Suh Ji-Hyung, Yang Seon-Young, Jang Eun-Jung, Lee Sung-Eun, Kim Dong-Wook

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

To analyze the pattern of multiple mutations detected by Sanger sequencing (SS), we performed subcloning sequencing using 218 samples from 45 patients with tyrosine kinase inhibitor resistant chronic myeloid leukemia. At the first time of multiple mutation detection by SS (baseline), a total of 19 major mutations from 45 samples were detected; these mutations were found in the following order: T315I (68.9%), E255 K (33.3%), Y253H (13.3%), G250E (13.3%), and F317 L (11.1%). Subcloning sequencing of 900 baseline colonies identified 556 different mutant types, and 791 among the 900 were colonies with major mutations (87.9%). The mutations were found in the following order: T315I (36.4%), E255 K (16.2%), Y253H (7.0%), G250E (6.7%), M351 T (6.6%), and E255 V (5.3%). In subcloning sequencing with 4357 colonies of 218 serial samples, 2506 colonies (57.5%) had compound mutations, among which 2238 colonies (89.3%) had at least one major mutation. The median number of mutations in compound mutant colonies was 2 (range, 2-7), and most were double (52.9%) or triple (28.7%) mutations. Additionally, some mutations in allosteric binding sites were detected as low level mutation in 13 patients. With the available retrospective samples before baseline, subcloning sequencing identified low-level mutations of various frequencies (median, 10%) to be major mutations in 20 patients. Thus, compound mutations involving T315I and P-loop mutations were the major components of multiple mutations, and some low-level mutations with potential clinical significance were detected by subcloning sequencing. Hence, more sensitive sequencing assays are needed in patients with multiple mutations.

Для цитирования: Kang Ki-Hoon, Kim Soo-Hyun, Choi Soo-Young, Yoo Hae-Lyun, Lee Mi-Young, Song Hye-Young, Kee Kyung-Mi, Suh Ji-Hyung, Yang Seon-Young, Jang Eun-Jung, Lee Sung-Eun, Kim Dong-Wook. Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.. Leukemia research. 2018. DOI: 10.1016/j.leukres.2018.10.019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.